Singapore markets closed

GRI Bio, Inc. (GRI)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.4100+0.0010 (+0.24%)
At close: 04:00PM EDT
0.4050 -0.00 (-1.22%)
After hours: 07:46PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.31M
Enterprise value -483.44k
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)5.06
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-99.08%
S&P500 52-week change 326.27%
52-week high 349.2800
52-week low 30.3750
50-day moving average 30.6090
200-day moving average 35.9995

Share statistics

Avg vol (3-month) 3299.45k
Avg vol (10-day) 387.56k
Shares outstanding 53.2M
Implied shares outstanding 63.2M
Float 83.06M
% held by insiders 14.18%
% held by institutions 10.78%
Shares short (30 Apr 2024) 416.25k
Short ratio (30 Apr 2024) 40.12
Short % of float (30 Apr 2024) 40.51%
Short % of shares outstanding (30 Apr 2024) 40.51%
Shares short (prior month 28 Mar 2024) 454.24k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:7
Last split date 330 Jan 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-416.93%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -11.13M
Net income avi to common (ttm)-13.04M
Diluted EPS (ttm)-28.2500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.81M
Total cash per share (mrq)0.57
Total debt (mrq)14k
Total debt/equity (mrq)5.41%
Current ratio (mrq)1.09
Book value per share (mrq)0.40

Cash flow statement

Operating cash flow (ttm)-8.99M
Levered free cash flow (ttm)-5.2M